{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:40:03Z","timestamp":1788518403968,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"DOI":"10.1007\/s00270-025-04001-1","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:29:58Z","timestamp":1741634998000},"page":"777-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased Voxel-Based Y90 Radioembolization Dose to Hepatocellular Carcinoma Improves Imaging Response"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-4563","authenticated-orcid":false,"given":"Shanmukha","family":"Srinivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Pianka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena D.","family":"Rockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Yeluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Liau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeet","family":"Minocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairine","family":"McNamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary T.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"4001_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s12325-016-0324-7","volume":"33","author":"JR Kallini","year":"2016","unstructured":"Kallini JR, Gabr A, Salem R, Lewandowski RJ. Transarterial radioembolization with Yttrium-90 for the treatment of hepatocellular carcinoma. Adv Ther. 2016;33:699\u2013714. https:\/\/doi.org\/10.1007\/s12325-016-0324-7.","journal-title":"Adv Ther"},{"key":"4001_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.tvir.2019.02.011","volume":"22","author":"BB Toskich","year":"2019","unstructured":"Toskich BB, Liu DM. Y90 radioembolization dosimetry: concepts for the interventional radiologist. Tech Vasc Interv Radiol. 2019;22:100\u201311. https:\/\/doi.org\/10.1053\/j.tvir.2019.02.011.","journal-title":"Tech Vasc Interv Radiol"},{"key":"4001_CR3","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.jvir.2018.07.006","volume":"29","author":"C Allimant","year":"2018","unstructured":"Allimant C, Kafrouni M, Delicque J, Ilonca D, Cassinotto C, Assenat E, et al. Tumor targeting and three-dimensional voxel-based dosimetry to predict tumor response, toxicity, and survival after Yttrium-90 resin microsphere radioembolization in hepatocellular carcinoma. J Vasc Interv Radiol. 2018;29:1662-1670.e4. https:\/\/doi.org\/10.1016\/j.jvir.2018.07.006.","journal-title":"J Vasc Interv Radiol"},{"key":"4001_CR4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jvir.2023.03.011","volume":"34","author":"GM Knight","year":"2023","unstructured":"Knight GM, Gordon AC, Gates V, Talwar A, Riaz A, Salem R, et al. Evolution of personalized dosimetry for radioembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2023;34:1214\u201325. https:\/\/doi.org\/10.1016\/j.jvir.2023.03.011.","journal-title":"J Vasc Interv Radiol"},{"key":"4001_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","volume":"7","author":"E Kim","year":"2022","unstructured":"Kim E, Sher A, Abboud G, Schwartz M, Facciuto M, Tabrizian P, et al. Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study. Lancet Gastroenterol Hepatol. 2022;7:843\u201350. https:\/\/doi.org\/10.1016\/S2468-1253(22)00091-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4001_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1200\/JCO.2021.39.3_suppl.300","volume":"39","author":"R Lewandowski","year":"2021","unstructured":"Lewandowski R, Johnson GE, Kim E, Riaz A, Bishay V, Padia S, et al. Use of Yttrium-90 (Y90) glass microspheres (TheraSphere) as neoadjuvant to transplantation\/resection in hepatocellular carcinoma: analyses from the LEGACY study. JCO. 2021;39:300\u2013300. https:\/\/doi.org\/10.1200\/JCO.2021.39.3_suppl.300.","journal-title":"JCO"},{"key":"4001_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","volume":"48","author":"A Gabr","year":"2021","unstructured":"Gabr A, Riaz A, Johnson GE, Kim E, Padia S, Lewandowski RJ, et al. Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants. Eur J Nucl Med Mol Imaging. 2021;48:580\u20133. https:\/\/doi.org\/10.1007\/s00259-020-04976-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4001_CR8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/MNM.0000000000001420","volume":"42","author":"B Cheng","year":"2021","unstructured":"Cheng B, Sethi I, Villalobos A, Wagstaff W, Schuster DM, Bercu Z, et al. Determination of tumour dose response threshold and implication on survival in patients with HCC treated with Y90 radiation segmentectomy: a simple semi-quantitative analysis. Nucl Med Commun. 2021;42:892. https:\/\/doi.org\/10.1097\/MNM.0000000000001420.","journal-title":"Nucl Med Commun"},{"key":"4001_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52\u201360. https:\/\/doi.org\/10.1055\/s-0030-1247132.","journal-title":"Semin Liver Dis"},{"key":"4001_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","volume":"79","author":"A Riaz","year":"2011","unstructured":"Riaz A, Gates VL, Atassi B, Lewandowski RJ, Mulcahy MF, Ryu RK, et al. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys. 2011;79:163\u201371. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.10.062.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4001_CR11","doi-asserted-by":"publisher","unstructured":"The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma\u2014Llovet\u20142004\u2014Liver Transplantation\u2014Wiley Online Library n.d. https:\/\/doi.org\/10.1002\/lt.20034. Accessed 11 March 2024","DOI":"10.1002\/lt.20034"},{"key":"4001_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fonc.2014.00255","volume":"4","author":"SM Srinivas","year":"2014","unstructured":"Srinivas SM, Natarajan N, Kuroiwa J, Gallagher S, Nasr E, Shah SN, et al. Determination of radiation absorbed dose to primary liver tumors and normal liver tissue using post-radioembolization 90Y PET. Front Oncol. 2014;4:255. https:\/\/doi.org\/10.3389\/fonc.2014.00255.","journal-title":"Front Oncol"},{"key":"4001_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/hep.27057","volume":"60","author":"M Vouche","year":"2014","unstructured":"Vouche M, Habib A, Ward TJ, Kim E, Kulik L, Ganger D, et al. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology. 2014;60:192\u2013201. https:\/\/doi.org\/10.1002\/hep.27057.","journal-title":"Hepatology"},{"key":"4001_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jvir.2023.03.005","volume":"34","author":"FE Boas","year":"2023","unstructured":"Boas FE, Maxwell AWP. Beyond mean tumor dose: the importance of particle density in radioembolization. J Vasc Interv Radiol. 2023;34:1235\u20136. https:\/\/doi.org\/10.1016\/j.jvir.2023.03.005.","journal-title":"J Vasc Interv Radiol"},{"key":"4001_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s00270-022-03139-6","volume":"45","author":"AWP Maxwell","year":"2022","unstructured":"Maxwell AWP, Mendoza HG, Sellitti MJ, Camacho JC, Deipolyi AR, Ziv E, et al. Optimizing 90Y particle density improves outcomes after radioembolization. Cardiovasc Intervent Radiol. 2022;45:958\u201369. https:\/\/doi.org\/10.1007\/s00270-022-03139-6.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4001_CR16","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jvir.2023.02.030","volume":"34","author":"A Villalobos","year":"2023","unstructured":"Villalobos A, Arndt L, Cheng B, Dabbous H, Loya M, Majdalany B, et al. Yttrium-90 radiation segmentectomy of hepatocellular carcinoma: a comparative study of the effectiveness, safety, and dosimetry of glass-based versus resin-based microspheres. J Vasc Interv Radiol. 2023;34:1226\u201334. https:\/\/doi.org\/10.1016\/j.jvir.2023.02.030.","journal-title":"J Vasc Interv Radiol"},{"key":"4001_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jvir.2020.12.019","volume":"32","author":"B Toskich","year":"2021","unstructured":"Toskich B, Vidal LL, Olson MT, Lewis JT, LeGout JD, Sella DM, et al. Pathologic response of hepatocellular carcinoma treated with Yttrium-90 glass microsphere radiation segmentectomy prior to liver transplantation: a validation study. J Vasc Interv Radiol. 2021;32:518-526.e1. https:\/\/doi.org\/10.1016\/j.jvir.2020.12.019.","journal-title":"J Vasc Interv Radiol"},{"key":"4001_CR18","doi-asserted-by":"publisher","first-page":"109351","DOI":"10.1016\/j.ejrad.2020.109351","volume":"133","author":"MJ King","year":"2020","unstructured":"King MJ, Tong A, Dane B, Huang C, Zhan C, Shanbhogue K. Response assessment of hepatocellular carcinoma treated with yttrium-90 radioembolization: inter-reader variability, comparison with 3D quantitative approach, and role in the prediction of clinical outcomes. Eur J Radiol. 2020;133:109351. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109351.","journal-title":"Eur J Radiol"},{"key":"4001_CR19","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jhep.2015.01.022","volume":"62","author":"BK Kim","year":"2015","unstructured":"Kim BK, Kim SU, Kim KA, Chung YE, Kim M-J, Park M-S, et al. Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. J Hepatol. 2015;62:1304\u201310. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.022.","journal-title":"J Hepatol"},{"key":"4001_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/00000658-196508000-00018","volume":"162","author":"IM Ariel","year":"1965","unstructured":"Ariel IM. Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres. Ann Surg. 1965;162:267\u201378.","journal-title":"Ann Surg"},{"key":"4001_CR21","first-page":"1673","volume":"41","author":"JE Dancey","year":"2000","unstructured":"Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med. 2000;41:1673\u201381.","journal-title":"J Nucl Med"},{"key":"4001_CR22","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1007\/s00259-022-05774-0","volume":"49","author":"M Lam","year":"2022","unstructured":"Lam M, Garin E, Maccauro M, Kappadath SC, Sze DY, Turkmen C, et al. A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study. Eur J Nucl Med Mol Imaging. 2022;49:3340\u201352. https:\/\/doi.org\/10.1007\/s00259-022-05774-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4001_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","volume":"6","author":"E Garin","year":"2021","unstructured":"Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6:17\u201329. https:\/\/doi.org\/10.1016\/S2468-1253(20)30290-9.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4001_CR24","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.hpb.2019.03.360","volume":"21","author":"I Labgaa","year":"2019","unstructured":"Labgaa I, Tabrizian P, Titano J, Kim E, Thung SN, Florman S, et al. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma. HPB. 2019;21:1497\u2013504. https:\/\/doi.org\/10.1016\/j.hpb.2019.03.360.","journal-title":"HPB"},{"key":"4001_CR25","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.jvir.2018.06.027","volume":"29","author":"A Gabr","year":"2018","unstructured":"Gabr A, Abouchaleh N, Ali R, Baker T, Caicedo J, Katariya N, et al. Outcomes of surgical resection after radioembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2018;29:1502-1510.e1. https:\/\/doi.org\/10.1016\/j.jvir.2018.06.027.","journal-title":"J Vasc Interv Radiol"},{"key":"4001_CR26","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/hep.22747","volume":"49","author":"A Riaz","year":"2009","unstructured":"Riaz A, Kulik L, Lewandowski RJ, Ryu RK, Giakoumis Spear G, Mulcahy MF, et al. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using Yttrium-90 microspheres. Hepatology. 2009;49:1185\u201393. https:\/\/doi.org\/10.1002\/hep.22747.","journal-title":"Hepatology"},{"key":"4001_CR27","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1007\/s00330-022-08732-4","volume":"32","author":"N Vietti Violi","year":"2022","unstructured":"Vietti Violi N, Gnerre J, Law A, Hectors S, Bane O, Doucette J, et al. Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology. Eur Radiol. 2022;32:6493\u2013503. https:\/\/doi.org\/10.1007\/s00330-022-08732-4.","journal-title":"Eur Radiol"},{"key":"4001_CR28","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00259-023-06111-9","volume":"50","author":"N Kokabi","year":"2023","unstructured":"Kokabi N, Arndt-Webster L, Chen B, Brandon D, Sethi I, Davarpanahfakhr A, et al. Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study. Eur J Nucl Med Mol Imaging. 2023;50:1743\u201352. https:\/\/doi.org\/10.1007\/s00259-023-06111-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4001_CR29","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1088\/0031-9155\/60\/5\/1945","volume":"60","author":"M Pacilio","year":"2015","unstructured":"Pacilio M, Amato E, Lanconelli N, Basile C, Torres LA, Botta F, et al. Differences in 3D dose distributions due to calculation method of voxel S-values and the influence of image blurring in SPECT. Phys Med Biol. 2015;60:1945. https:\/\/doi.org\/10.1088\/0031-9155\/60\/5\/1945.","journal-title":"Phys Med Biol"},{"key":"4001_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3109\/0284186X.2011.584559","volume":"50","author":"M Ljungberg","year":"2011","unstructured":"Ljungberg M, Sj\u00f6green-Gleisner K. The accuracy of absorbed dose estimates in tumours determined by quantitative SPECT: a Monte Carlo study. Acta Oncol. 2011;50:981\u20139. https:\/\/doi.org\/10.3109\/0284186X.2011.584559.","journal-title":"Acta Oncol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04001-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-025-04001-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04001-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T14:16:07Z","timestamp":1750083367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-025-04001-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["4001"],"URL":"https:\/\/doi.org\/10.1007\/s00270-025-04001-1","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study has obtained IRB approval from UCSD IRB # 804092. The need for informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"All authors have reviewed this manuscript and support its submission. The need for informed consent from those involved in the study was waived due to its retrospective nature.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}